Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion

Patricia Udaondo1,2, Salvador Garcia-Delpech1,3, David Salom1,3, Maria Garcia-Pous1,3, Manuel Diaz-Llopis1,31Nuevo Hospital Universitario y Politecnico La Fe, Valencia, Spain; 2University Cardenal Herrera CEU, Valencia, Spain; 3Faculty of Medicine, University of Valencia, Valencia, SpainPurpose: To...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Udaondo P, Garcia-Delpech S, Salom D, Garcia-Pous M, Diaz-Llopis M.
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://doaj.org/article/c39c876695004519b25417e3291cafda
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c39c876695004519b25417e3291cafda
record_format dspace
spelling oai:doaj.org-article:c39c876695004519b25417e3291cafda2021-12-02T11:21:05ZIntravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion1177-54671177-5483https://doaj.org/article/c39c876695004519b25417e3291cafda2011-07-01T00:00:00Zhttp://www.dovepress.com/intravitreal-pegaptanib-for-refractory-macular-edema-secondary-to-reti-a7821https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Patricia Udaondo1,2, Salvador Garcia-Delpech1,3, David Salom1,3, Maria Garcia-Pous1,3, Manuel Diaz-Llopis1,31Nuevo Hospital Universitario y Politecnico La Fe, Valencia, Spain; 2University Cardenal Herrera CEU, Valencia, Spain; 3Faculty of Medicine, University of Valencia, Valencia, SpainPurpose: To assess the efficacy of intravitreal Pegaptanib sodium (Macugen®) injection in the management of refractory macular edema secondary to branch retinal vein occlusion.Methods: This is a prospective, nonrandomized, interventional case series. Five eyes of five patients with macular edema refractory to either bevacizumab or triamcinolone were treated with intravitreal injection of Pegaptanib sodium.Results: After three months follow-up, both visual acuity and macular edema, measured by optical coherence tomography and fluorescence angiography, dramatically improved.Conclusion: Pegaptanib sodium is a safe and efficacy treatment for macular edema secondary to branch retinal vein occlusion.Keywords: Macugen®, BRVO, BCVA, pegaptanib sodiumUdaondo PGarcia-Delpech SSalom DGarcia-Pous MDiaz-Llopis M.Dove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2011, Iss default, Pp 941-944 (2011)
institution DOAJ
collection DOAJ
language EN
topic Ophthalmology
RE1-994
spellingShingle Ophthalmology
RE1-994
Udaondo P
Garcia-Delpech S
Salom D
Garcia-Pous M
Diaz-Llopis M.
Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion
description Patricia Udaondo1,2, Salvador Garcia-Delpech1,3, David Salom1,3, Maria Garcia-Pous1,3, Manuel Diaz-Llopis1,31Nuevo Hospital Universitario y Politecnico La Fe, Valencia, Spain; 2University Cardenal Herrera CEU, Valencia, Spain; 3Faculty of Medicine, University of Valencia, Valencia, SpainPurpose: To assess the efficacy of intravitreal Pegaptanib sodium (Macugen®) injection in the management of refractory macular edema secondary to branch retinal vein occlusion.Methods: This is a prospective, nonrandomized, interventional case series. Five eyes of five patients with macular edema refractory to either bevacizumab or triamcinolone were treated with intravitreal injection of Pegaptanib sodium.Results: After three months follow-up, both visual acuity and macular edema, measured by optical coherence tomography and fluorescence angiography, dramatically improved.Conclusion: Pegaptanib sodium is a safe and efficacy treatment for macular edema secondary to branch retinal vein occlusion.Keywords: Macugen®, BRVO, BCVA, pegaptanib sodium
format article
author Udaondo P
Garcia-Delpech S
Salom D
Garcia-Pous M
Diaz-Llopis M.
author_facet Udaondo P
Garcia-Delpech S
Salom D
Garcia-Pous M
Diaz-Llopis M.
author_sort Udaondo P
title Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion
title_short Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion
title_full Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion
title_fullStr Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion
title_full_unstemmed Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion
title_sort intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion
publisher Dove Medical Press
publishDate 2011
url https://doaj.org/article/c39c876695004519b25417e3291cafda
work_keys_str_mv AT udaondop intravitrealpegaptanibforrefractorymacularedemasecondarytoretinalveinocclusion
AT garciadelpechs intravitrealpegaptanibforrefractorymacularedemasecondarytoretinalveinocclusion
AT salomd intravitrealpegaptanibforrefractorymacularedemasecondarytoretinalveinocclusion
AT garciapousm intravitrealpegaptanibforrefractorymacularedemasecondarytoretinalveinocclusion
AT diazllopism intravitrealpegaptanibforrefractorymacularedemasecondarytoretinalveinocclusion
_version_ 1718396015489318912